Dehydroepiandrosterone sulfate indicates decreased sulfation capacity and impaired quality of life in patients with primary sclerosing cholangitis.

Wronka, Karolina M; Wunsch, Ewa; Kozlowska-Petriczko, Katarzyna; Wójcicki, Maciej; Kruk, Beata; Milkiewicz, Piotr

Wronka, Karolina M; Wunsch, Ewa; Kozlowska-Petriczko, Katarzyna; Wójcicki, Maciej; Kruk, Beata; Milkiewicz, Piotr.

Afiliação

Wronka KM; Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland
Wunsch E; Translational Medicine Group, Pomeranian Medical University, Szczecin, Poland
Kozlowska-Petriczko K; Translational Medicine Group, Pomeranian Medical University, Szczecin, Poland
Wójcicki M; Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland
Kruk B; Laboratory of Metabolic Liver Diseases, Center for Preclinical Research, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland
Milkiewicz P; Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland; Translational Medicine Group, Pomeranian Medical University, Szczecin, Poland. p.milkiewicz@wp.pl

Pol Arch Intern Med ; 131(9): 790-796, 2021 09 30.

Article em En | MEDLINE | ID: mdl-34132084

Assuntos

Colangite Esclerosante; Qualidade de Vida; Biomarcadores; Sulfato de Desidroepiandrosterona; Humanos; Fígado

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Colangite Esclerosante Limite: Humans Idioma: En Revista: Pol Arch Intern Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google